[1]
2025. EFFECT OF PERSONALIZED GENOMIC-GUIDED CHEMOTHERAPY REGIMENS ON TREATMENT OUTCOMES IN BRCA-MUTATED BREAST CANCER PATIENTS. Axis Journal of Medical and Biosocial Sciences. 2, 1 (Feb. 2025), 15–26.